594 related articles for article (PubMed ID: 29771487)
1. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination.
Yang R; Xu J; Xu L; Sun X; Chen Q; Zhao Y; Peng R; Liu Z
ACS Nano; 2018 Jun; 12(6):5121-5129. PubMed ID: 29771487
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
[TBL] [Abstract][Full Text] [Related]
3. Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer.
Chen Q; Zhang L; Li L; Tan M; Liu W; Liu S; Xie Z; Zhang W; Wang Z; Cao Y; Shang T; Ran H
J Nanobiotechnology; 2021 Dec; 19(1):449. PubMed ID: 34952587
[TBL] [Abstract][Full Text] [Related]
4. Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy.
Kokate RA; Chaudhary P; Sun X; Thamake SI; Maji S; Chib R; Vishwanatha JK; Jones HP
Nanomedicine (Lond); 2016; 11(5):479-94. PubMed ID: 26892440
[TBL] [Abstract][Full Text] [Related]
5. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.
Han HD; Byeon Y; Kang TH; Jung ID; Lee JW; Shin BC; Lee YJ; Sood AK; Park YM
Int J Nanomedicine; 2016; 11():5729-5742. PubMed ID: 27843314
[TBL] [Abstract][Full Text] [Related]
8. Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy.
Liu Z; Liu B; Feng Y; Zhao L; Wang Q; He H; Yin T; Zhang Y; Yang L; Gou J; Tang X
ACS Nano; 2024 Jun; 18(24):15557-15575. PubMed ID: 38837909
[TBL] [Abstract][Full Text] [Related]
9. Selective Tumor-Specific Antigen Delivery to Dendritic Cells Using Mannose-Labeled Poly(d, l-lactide-co-glycolide) Nanoparticles for Cancer Immunotherapy.
Wi TI; Byeon Y; Won JE; Lee JM; Kang TH; Lee JW; Lee YJ; Sood AK; Han HD; Park YM
J Biomed Nanotechnol; 2020 Feb; 16(2):201-211. PubMed ID: 32252881
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination.
Zhu D; Hu C; Fan F; Qin Y; Huang C; Zhang Z; Lu L; Wang H; Sun H; Leng X; Wang C; Kong D; Zhang L
Biomaterials; 2019 Jun; 206():25-40. PubMed ID: 30925286
[TBL] [Abstract][Full Text] [Related]
11. Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles.
Bocanegra Gondan AI; Ruiz-de-Angulo A; Zabaleta A; Gómez Blanco N; Cobaleda-Siles BM; García-Granda MJ; Padro D; Llop J; Arnaiz B; Gato M; Escors D; Mareque-Rivas JC
Biomaterials; 2018 Jul; 170():95-115. PubMed ID: 29656235
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
[TBL] [Abstract][Full Text] [Related]
13. PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy.
Koerner J; Horvath D; Herrmann VL; MacKerracher A; Gander B; Yagita H; Rohayem J; Groettrup M
Nat Commun; 2021 May; 12(1):2935. PubMed ID: 34006895
[TBL] [Abstract][Full Text] [Related]
14. Multi-functional nanocomplex codelivery of Trp2 and R837 to activate melanoma-specific immunity.
Ji Z; Tan Z; Li M; Tao J; Guan E; Du J; Hu Y
Int J Pharm; 2020 May; 582():119310. PubMed ID: 32276088
[TBL] [Abstract][Full Text] [Related]
15. Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle Vaccine.
Zhang Q; Huang W; Yuan M; Li W; Hua L; Yang Z; Gao F; Li S; Ye C; Chen Y; He J; Sun W; Yang X; Bai H; Ma Y
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54399-54414. PubMed ID: 33215918
[TBL] [Abstract][Full Text] [Related]
16. Polydopamine nanoparticles cross-linked hyaluronic acid photothermal hydrogel with cascading immunoinducible effects for in situ antitumor vaccination.
Fang Z; Yan Z; Li Z; Yan C; Jia S; Qiu X; Wang Q; Hou H; Wu Y; Du F; Gong A; Zhang M
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132177. PubMed ID: 38729484
[TBL] [Abstract][Full Text] [Related]
17. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
Aikins ME; Xu C; Moon JJ
Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
[TBL] [Abstract][Full Text] [Related]
18. Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer.
Sheikhzadeh S; Delirezh N; Hobbenaghi R
Biomed Pharmacother; 2021 Oct; 142():111962. PubMed ID: 34358752
[TBL] [Abstract][Full Text] [Related]
19. PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy.
Ochyl LJ; Bazzill JD; Park C; Xu Y; Kuai R; Moon JJ
Biomaterials; 2018 Nov; 182():157-166. PubMed ID: 30121425
[TBL] [Abstract][Full Text] [Related]
20. Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy.
Pan Y; Wu X; Liu L; Zhao C; Zhang J; Yang S; Pan P; Huang Q; Zhao XZ; Tian R; Rao L
Adv Healthc Mater; 2024 May; 13(13):e2400068. PubMed ID: 38320299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
